| RS2115046344 |
CARD11
|
Health Risk |
Likely pathogenic |
BENTA disease, Severe combined immunodeficiency due to CARD11 deficiency |
| RS2115070994 |
CARD11
|
Health Risk |
Pathogenic |
BENTA disease, BENTA disease |
| RS2115075051 |
CARD11
|
Health Risk |
Pathogenic |
BENTA disease, Severe combined immunodeficiency due to CARD11 deficiency |
| RS2115075086 |
CARD11
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to CARD11 deficiency, BENTA disease |
| RS2115087153 |
CARD11
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to CARD11 deficiency, BENTA disease |
| RS2115090359 |
CARD11
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 11b with atopic dermatitis, Severe combined immunodeficiency due to CARD11 deficiency |
| RS2115090664 |
CARD11
|
Health Risk |
Conflicting classifications of pathogenicity |
BENTA disease, Severe combined immunodeficiency due to CARD11 deficiency |
| RS2115093887 |
CARD11
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 11b with atopic dermatitis, BENTA disease |
| RS2115094112 |
CARD11
|
Health Risk |
Likely pathogenic |
Immunodeficiency 11b with atopic dermatitis, BENTA disease |
| RS2115103191 |
AP5Z1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia, Hereditary spastic paraplegia |
| RS2115114032 |
AP5Z1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia 48 |
| RS2115118331 |
AP5Z1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia 48 |
| RS2115122331 |
AP5Z1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia 48 |
| RS2115122515 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2115122957 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2115128968 |
AP5Z1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia 48 |
| RS2115129048 |
PEX7
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2115129514 |
AP5Z1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia 48 |
| RS2115131765 |
PEX7
|
Health Risk |
Likely pathogenic |
Abnormality of metabolism/homeostasis, Abnormality of metabolism/homeostasis |
| RS2115131935 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2115167557 |
HACE1
|
Health Risk |
Pathogenic |
Spastic paraplegia-severe developmental delay-epilepsy syndrome, Spastic paraplegia-severe developmental delay-epilepsy syndrome |
| RS2115170460 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2115170536 |
PEX7
|
Health Risk |
Pathogenic/Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Peroxisome biogenesis disorder 9B |
| RS2115171312 |
FAM20C
|
Health Risk |
Pathogenic |
Lethal osteosclerotic bone dysplasia, Lethal osteosclerotic bone dysplasia |
| RS2115171634 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2115171791 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2115173146 |
FAM20C
|
Health Risk |
Likely pathogenic |
Lethal osteosclerotic bone dysplasia, Lethal osteosclerotic bone dysplasia |
| RS2115181746 |
PLG
|
Health Risk |
Likely pathogenic |
Plasminogen deficiency, type I |
| RS2115201389 |
RAC1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 48 |
| RS2115201406 |
RAC1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 48 |
| RS2115201430 |
RAC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 48 |
| RS2115201441 |
RAC1
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, Intellectual disability |
| RS2115216571 |
PEX7
|
Health Risk |
Likely pathogenic |
Intermediate form of PEX7 related rhizomelic chondrodysplasia punctata, Intermediate form of PEX7 related rhizomelic chondrodysplasia punctata |
| RS2115216632 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2115218399 |
RAC1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 48 |
| RS2115218501 |
RAC1
|
Health Risk |
Likely pathogenic |
— |
| RS2115273041 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS2115280647 |
WIPI2
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with short stature and variable skeletal anomalies, Intellectual developmental disorder with short stature and variable skeletal anomalies |
| RS2115322443 |
CEP85L
|
Health Risk |
Pathogenic |
Lissencephaly, Thick corpus callosum |
| RS2115322620 |
CEP85L
|
Health Risk |
Likely pathogenic |
Lissencephaly, Lissencephaly |
| RS2115322699 |
CEP85L
|
Health Risk |
Conflicting classifications of pathogenicity |
Lissencephaly 10, Lissencephaly 10 |
| RS2115340270 |
MICAL1
|
Health Risk |
Pathogenic |
Epilepsy, familial temporal lobe |
| RS2115351044 |
RSPH4A
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2115351492 |
RSPH4A
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2115362230 |
RSPH4A
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2115362674 |
RSPH4A
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 11, Primary ciliary dyskinesia 11 |
| RS2115364513 |
AHR
|
Health Risk |
Likely pathogenic |
— |
| RS2115370127 |
AHR
|
Health Risk |
Pathogenic |
— |
| RS2115386562 |
CEP85L;LOC129997071
|
Health Risk |
Pathogenic |
Lissencephaly, Lissencephaly |
| RS2115396414 |
TWIST1
|
Health Risk |
Pathogenic |
TWIST1-related craniosynostosis, Saethre-Chotzen syndrome |
| RS2115396572 |
TWIST1
|
Health Risk |
Likely pathogenic |
Saethre-Chotzen syndrome, TWIST1-related craniosynostosis |
| RS2115396574 |
TWIST1
|
Health Risk |
Likely pathogenic |
Saethre-Chotzen syndrome, TWIST1-related craniosynostosis |
| RS2115396578 |
TWIST1
|
Health Risk |
Pathogenic |
Saethre-Chotzen syndrome, TWIST1-related craniosynostosis |
| RS2115396610 |
TWIST1
|
Health Risk |
Pathogenic |
Saethre-Chotzen syndrome, Saethre-Chotzen syndrome |
| RS2115396618 |
TWIST1
|
Health Risk |
Likely pathogenic |
— |
| RS2115396651 |
TWIST1
|
Health Risk |
Likely pathogenic |
TWIST1-related craniosynostosis, Saethre-Chotzen syndrome |
| RS2115396671 |
TWIST1
|
Health Risk |
Pathogenic |
Saethre-Chotzen syndrome, TWIST1-related craniosynostosis |
| RS2115396737 |
TWIST1
|
Health Risk |
Likely pathogenic |
Saethre-Chotzen syndrome, Saethre-Chotzen syndrome |
| RS2115396763 |
TWIST1
|
Health Risk |
Pathogenic |
Saethre-Chotzen syndrome, TWIST1-related craniosynostosis |
| RS2115396782 |
TWIST1
|
Health Risk |
Pathogenic |
Saethre-Chotzen syndrome, TWIST1-related craniosynostosis |
| RS2115396985 |
TWIST1
|
Health Risk |
Pathogenic |
Saethre-Chotzen syndrome, TWIST1-related craniosynostosis |
| RS2115397200 |
TWIST1
|
Health Risk |
Pathogenic |
— |
| RS2115397248 |
TWIST1
|
Health Risk |
Pathogenic |
TWIST1-related craniosynostosis, Saethre-Chotzen syndrome |
| RS2115426221 |
PRKN
|
Health Risk |
Pathogenic |
Autosomal recessive juvenile Parkinson disease 2, Autosomal recessive juvenile Parkinson disease 2 |
| RS2115573262 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS2115578318 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS2115582108 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS2115582732 |
ASNS
|
Health Risk |
Pathogenic |
— |
| RS2115587401 |
YWHAG
|
Health Risk |
Likely pathogenic |
— |
| RS2115589045 |
YWHAG
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 56 |
| RS2115589147 |
YWHAG
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 56 |
| RS2115589275 |
YWHAG
|
Health Risk |
Pathogenic |
Bilateral tonic-clonic seizure, Specific learning disability |
| RS2115589280 |
YWHAG
|
Health Risk |
Pathogenic |
— |
| RS2115590426 |
ASNS
|
Health Risk |
Pathogenic |
— |
| RS2115591817 |
ASNS
|
Health Risk |
Pathogenic |
— |
| RS2115592556 |
ASNS
|
Health Risk |
Likely pathogenic |
Abnormal cerebral morphology, Abnormal cerebral morphology |
| RS2115593984 |
ASNS
|
Health Risk |
Pathogenic |
— |
| RS2115608786 |
ASNS
|
Health Risk |
Likely pathogenic |
— |
| RS2115608872 |
ASNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome, Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome |
| RS2115616730 |
ASNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome, Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome |
| RS2115631937 |
GNAI1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, impaired speech |
| RS2115649654 |
ASNS
|
Health Risk |
Likely pathogenic |
— |
| RS2115649690 |
ASNS
|
Health Risk |
Pathogenic |
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome, Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome |
| RS2115654584 |
ASNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome, Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome |
| RS2115654665 |
SEMA3E
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2115655031 |
ASNS
|
Health Risk |
Pathogenic |
— |
| RS2115655242 |
ASNS
|
Health Risk |
Pathogenic |
— |
| RS2115655369 |
ASNS
|
Health Risk |
Pathogenic |
— |
| RS2115657314 |
PCLO
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2115660227 |
ASNS
|
Health Risk |
Pathogenic |
— |
| RS2115660310 |
ASNS
|
Health Risk |
Pathogenic |
— |
| RS2115661145 |
ASNS
|
Health Risk |
Pathogenic |
— |
| RS2115667069 |
YWHAG
|
Health Risk |
Pathogenic |
— |
| RS2115683966 |
GNAI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with hypotonia, impaired speech |
| RS2115694416 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS2115698756 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS2115700686 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS2115710819 |
ASNS
|
Health Risk |
Likely pathogenic |
— |
| RS2115712676 |
GNAI1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, impaired speech |
| RS2115712706 |
GNAI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with hypotonia, impaired speech |